» Authors » Ronald C Petersen

Ronald C Petersen

Explore the profile of Ronald C Petersen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 994
Citations 74277
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mak E, Przybelski S, Wiste H, Fought A, Schwarz C, Senjem M, et al.
Alzheimers Dement . 2025 Feb; 21(2):e14571. PMID: 39935389
Introduction: We investigated the association between alpha-synuclein (α-syn) pathology and brain glucose metabolism across the cognitive spectrum of Alzheimer's disease (AD) co-pathologies. Methods: Fluorodeoxyglucose positron emission tomography (FDG-PET) data from...
12.
Behnam A, Garg M, Liu X, Vassilaki M, St Sauver J, Petersen R, et al.
Proceedings (IEEE Int Conf Bioinformatics Biomed) . 2025 Feb; 2024:6349-6355. PMID: 39926363
Mild Cognitive Impairment (MCI) is a transitional stage between normal cognitive aging and dementia. Some individuals with MCI revert to normal, while others progress to dementia. There are limited studies...
13.
Elasfar S, Hameed H, Boeve B, Fields J, Jack Jr C, Kantarci K, et al.
Alzheimers Dement . 2025 Jan; 21(2):e14351. PMID: 39868511
Introduction: We aimed to compare gait between individuals with Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and cognitively unimpaired (CU) individuals and to evaluate the association between gait and...
14.
Bornhorst J, Lundgreen C, Weigand S, Figdore D, Wiste H, Griswold M, et al.
Neurology . 2025 Jan; 104(3):e210287. PMID: 39823562
Background And Objectives: Chronic kidney disease (CKD) is known to be associated with increased plasma phosphorylated tau217 (p-tau217) concentrations, potentially confounding the utility of plasma p-tau217 measurements as a marker...
15.
Carlos A, Weigand S, Pham N, Petersen R, Jack Jr C, Dickson D, et al.
Alzheimers Dement . 2025 Jan; 21(2):ealz14516. PMID: 39821594
Introduction: Greater white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are seen with transactive response DNA-binding protein 43 (TDP-43) pathology in frontotemporal lobar degeneration (FTLD-TDP). WMH associations with TDP-43...
16.
Ali F, Syrjanen J, Figdore D, Kremers W, Mielke M, Jack C, et al.
Commun Med (Lond) . 2025 Jan; 5(1):19. PMID: 39820537
Background: Declining gait performance is seen in aging individuals, due to neural and systemic factors. Plasma biomarkers provide an accessible way to assess evolving brain changes; non-specific neurodegeneration (NfL, GFAP)...
17.
Wolk D, Nelson P, Apostolova L, Arfanakis K, Boyle P, Carlsson C, et al.
Alzheimers Dement . 2025 Jan; 21(1):e14202. PMID: 39807681
Limbic predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is highly prevalent in late life and a common co-pathology with Alzheimer's disease neuropathologic change (ADNC). LATE-NC is a slowly progressive, amnestic...
18.
Ferreira D, Przybelski S, Lesnick T, Diaz-Galvan P, Schwarz C, Murray M, et al.
JAMA Neurol . 2025 Jan; 82(3):285-294. PMID: 39804619
Importance: Although 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established cross-sectional biomarker of brain metabolism in dementia with Lewy bodies (DLB), the longitudinal change in FDG-PET has not been characterized....
19.
Shah J, Krell-Roesch J, Forzani E, Knopman D, Jack C, Petersen R, et al.
J Alzheimers Dis . 2025 Jan; 103(3):833-843. PMID: 39791216
Background: The aim of this study was to examine the potential added value of including neuropsychiatric symptoms (NPS) in machine learning (ML) models, along with demographic features and Alzheimer's disease...
20.
Garg M, Liu X, Lin J, Vassilaki M, Petersen R, St Sauver J, et al.
medRxiv . 2025 Jan; PMID: 39763541
Rationale: A scoping review was conducted to investigate knowledge gaps in the informatics research literature regarding sex differences in cognitive decline, identifying existing studies and areas where further studies are...